GlassScriptPhysician profile
Amy Katheryne Titus
NPI 1104699941
$1,163.40
in general payments reported to CMS, 2019-2025
13 companies · $896 in 2025
The $896 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $19.99 · 2024: $248 · 2025: $896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837 · Travel and Lodging: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.77 |
| Travel and Lodging | $326.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $448.15 | 2025 | Barrigel |
| Sumitomo Pharma America, INC. | $139.21 | 2024-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $130.69 | 2024-2025 | |
| Telix Pharmaceuticals | $124.95 | 2025 | Illuccix |
| Boston Scientific Corporation | $78.33 | 2025 | Axonics, Solyx Sis System, Upsylon |
| Janssen Biotech, INC. | $50.74 | 2024-2025 | Erleada, Akeega |
| Calyxo, INC. | $40.00 | 2024-2025 | Cvac Aspiration System |
| Convatec INC. | $32.27 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.96 | 2025 | |
| Abc Home Medical Supply, INC. | $26.31 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $24.41 | 2025 | Bard Urinary Drainage Bag |
| Astellas Pharma US INC | $20.39 | 2025 | Xtandi |
| Sanofi Pasteur INC. | $19.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Titus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.